<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01790529</url>
  </required_header>
  <id_info>
    <org_study_id>SSI-19/12</org_study_id>
    <nct_id>NCT01790529</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis</brief_title>
  <official_title>Randomized Controlled Trial to Evaluate the Optimal Timing of Surgical Antimicrobial Prophylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cantonal Hospital of Aarau, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical site infections (SSI) are the most frequent hospital acquired infections in patients&#xD;
      who underwent surgery. With regards to the increasing financial restraint in patient care,&#xD;
      the socio-economic burden of SSI in the public health sector and its prevention gains in&#xD;
      importance.&#xD;
&#xD;
      The prophylactic application of antibiotics (surgical antimicrobial prophylaxis, SAP) prior&#xD;
      to the skin incision significantly reduces the risk of SSI, but the correct time point of&#xD;
      drug administration remains unclear. Most studies recommend application of SAP directly prior&#xD;
      to skin incision. Other studies, however, suggest that this is too late and more time between&#xD;
      administration of the SAP and skin incision is necessary for optimal SSI prevention. A large&#xD;
      cohort study in Switzerland concluded that SAP should be applied between 74 and 30 minutes&#xD;
      prior to skin incision.&#xD;
&#xD;
      Due to the obvious importance of this controversy, we want to answer this question with a&#xD;
      clinical study (randomized controlled trial, RCT) at the University Hospital of Basel and the&#xD;
      Cantonal Hospital of Aarau. We plan to investigate two administration strategies according to&#xD;
      the timing of the SAP. Strategy A will consist of SAP application in the anesthetic room&#xD;
      located in front of the actual operating theatre, where the patient gets anesthesia.&#xD;
      Therefore, the application of SAP will take place early, approximately between 75 and 30&#xD;
      minutes prior to skin incision. In strategy B we will apply SAP in the operating theatre,&#xD;
      which on average occurs later (approximately within the last 30 minutes before skin&#xD;
      incision).&#xD;
&#xD;
      We test the hypothesis that strategy A is more effective in preventing SSI than strategy B.&#xD;
      We will include a total of 5000 patients in abdominal, vascular and trauma surgery (2500 at&#xD;
      each study site and 2500 per study group). All patients will be followed in the hospital for&#xD;
      SSI occurrence. Additionally, all patients will be interviewed by telephone after hospital&#xD;
      discharge at a defined follow-up period of 30 days (1 year if an implant is in place, such as&#xD;
      hip endoprosthesis or meshes). We expect this study to be completed within approximately 3&#xD;
      years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Additionally, the association between the following pre-defined variables and the occurence&#xD;
      of SSI, mortality, morbidity and length of hospital stay (LOS) will be investigated:&#xD;
&#xD;
        -  laparoscopy&#xD;
&#xD;
        -  tutorial assistance during operation&#xD;
&#xD;
        -  obesity (Body Mass Index, BMI)&#xD;
&#xD;
        -  preoperative Virtual Reality (VR) training&#xD;
&#xD;
        -  Adherence to Enhanced Recovery After Surgery (ERAS) concept&#xD;
&#xD;
        -  smoking status&#xD;
&#xD;
        -  perioperative blood glucose levels&#xD;
&#xD;
        -  preoperative levels of HbA1c&#xD;
&#xD;
        -  intensified insulin resistance as measured by Homeostasis Model Assessment (HOMA) and&#xD;
           quantitative insulin-sensitivity check index (QUICKI)&#xD;
&#xD;
        -  type of diabetes (IDDM vs. NIDDM)&#xD;
&#xD;
        -  intraoperative Hypothermia (body core temperature)&#xD;
&#xD;
        -  Lack of adherence to the principles of asepsis during surgery&#xD;
&#xD;
        -  surgical experience&#xD;
&#xD;
        -  patients age&#xD;
&#xD;
        -  Malnutrition, measured by Hypalbuminaemia&#xD;
&#xD;
        -  emergency operations&#xD;
&#xD;
        -  immunosuppression and steroids&#xD;
&#xD;
        -  Predictive value of Procalcitonin&#xD;
&#xD;
        -  American Society of Anesthesiologists (ASA) classification&#xD;
&#xD;
        -  intraoperative blood transfusion&#xD;
&#xD;
        -  preoperative wound class&#xD;
&#xD;
      Amendments:&#xD;
&#xD;
      The following changes were made to the study protocol according to amendments approved by the&#xD;
      local ethics committee:&#xD;
&#xD;
        -  As of April 22nd, 2013, or the 222. patient randomized at the University Hospital Basel,&#xD;
           the time the SAP infusion STARTED was recorded instead of the time that it ENDED. The&#xD;
           decision to change this important parameter was taken in order to make results of this&#xD;
           trial more comparable to those of other published studies.&#xD;
&#xD;
        -  In the original study protocol it was planned to provide each randomized patient with a&#xD;
           patient's diary to record signs of SSI. This was abandoned for limited benefit and in&#xD;
           order to minimize patients' time and effort.&#xD;
&#xD;
        -  Patients who undergo combined surgery (by one of the participating surgical specialties&#xD;
           plus by a non participating specialty) shall not be included in this trial as outcomes&#xD;
           (SSI) could be difficult to correlate to one or another part of surgery. This had not&#xD;
           been specified as an exclusion criterion in the original study protocol.&#xD;
&#xD;
        -  Patients' information sheets and informed consents in one of the languages other than&#xD;
           German were only approved by the local ethics committees by May 15th, 2013.&#xD;
&#xD;
        -  As per ethics committees regulations, patients can only be included in more than one&#xD;
           clinical trials under specific circumstances. Therefore only a limited percentage of&#xD;
           patients that are already included in other studies can still be included for this&#xD;
           trial. However, overall, this only excludes a very limited number of potentially&#xD;
           includable patients.&#xD;
&#xD;
      The following additional amendments were authorized by the ethics committees on August 9th,&#xD;
      2014:&#xD;
&#xD;
      - Version 4 of the patients' information and the written consent form. In these new versions,&#xD;
      patients are specifically asked for permission to review their general practitioners' notes&#xD;
      concerning potential SSI, for planned follow up as well as in case of readmission to&#xD;
      hospital. This is specified in the study protocol, but had not been specifically mentioned in&#xD;
      the patients' information and consent forms. This change is also intended to significantly&#xD;
      decrease the number of patients lost to follow up as it proved difficult to contact some&#xD;
      patients by telephone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Site Infection (SSI)</measure>
    <time_frame>30 days</time_frame>
    <description>Surgical Site Infection within 30 days after index surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause 30 day mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic burden of SSI</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nosocomial infections</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital complications</measure>
    <time_frame>1 year</time_frame>
    <description>according to the Clavien-Dindo-Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Site Infection (SSI)</measure>
    <time_frame>1 year</time_frame>
    <description>Surgical Site Infection within 1 year after surgery only for implant surgeries</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5000</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Early Prophylaxis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in anesthetic room (75 to 30 minutes prior to skin incision)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Prophylaxis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in anesthetic room (75 to 30 minutes prior to skin incision)</intervention_name>
    <arm_group_label>Early Prophylaxis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Late administration of SAP (Cefuroxime (plus metronidazole in colorectal surgery)) in the operating theatre (within 30 minutes prior to skin incision)</intervention_name>
    <arm_group_label>Late Prophylaxis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Inpatient visceral, vascular and trauma procedures&#xD;
&#xD;
          -  SAP indicated according to clinical standards (CDC guidelines for surgical wound&#xD;
             classification)&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication for study drugs&#xD;
&#xD;
          -  Pre-existing antibiotic therapy within 14 days of surgery&#xD;
&#xD;
          -  Any doubt that patients can make the decision to participate fully informed due to&#xD;
             cognitive impairment, such as in critically ill or demented patients.&#xD;
&#xD;
          -  Emergency procedures with planned incision within 2 hours after the surgeon indicated&#xD;
             the procedure&#xD;
&#xD;
          -  Participation in other studies that could potentially interfere with the present one&#xD;
             (according to the ethics committee)&#xD;
&#xD;
          -  Combined surgery including surgical subspecialties other than the above mentioned&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walter P. Weber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Basel, Basel 4031 Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Baselstadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>February 5, 2013</study_first_submitted>
  <study_first_submitted_qc>February 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2013</study_first_posted>
  <last_update_submitted>September 28, 2016</last_update_submitted>
  <last_update_submitted_qc>September 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Cefuroxime</mesh_term>
    <mesh_term>Cefuroxime axetil</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

